Philip Bath
Philip Bath
Stroke Association Professor of Stroke Medicine, University of Nottingham
Verified email at nottingham.ac.uk - Homepage
TitleCited byYear
Guidelines for management of ischaemic stroke and transient ischaemic attack 2008
European Stroke Organisation (ESO) Executive Committee, ...
Cerebrovascular diseases 25 (5), 457-507, 2008
17362008
Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke
RL Sacco, HC Diener, S Yusuf, D Cotton, S Ōunpuu, WA Lawton, ...
New England Journal of Medicine 359 (12), 1238-1251, 2008
9772008
The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST …
IST-3 Collaborative Group
The Lancet 379 (9834), 2352-2363, 2012
9752012
Platelet size: measurement, physiology and vascular disease.
PM Bath, RJ Butterworth
Blood coagulation & fibrinolysis: an international journal in haemostasis …, 1996
8701996
European stroke initiative recommendations for stroke management–update 2003
GE Carlsson, A Möller, C Blomstrand, T Ueda, K Mizushige, K Yukiiri, ...
Cerebrovascular Diseases 16 (4), 311-337, 2003
8492003
Blood pressure and clinical outcomes in the International Stroke Trial
J Leonardi-Bee, PMW Bath, SJ Phillips, PAG Sandercock
Stroke 33 (5), 1315-1320, 2002
8172002
Telmisartan to prevent recurrent stroke and cardiovascular events
S Yusuf, HC Diener, RL Sacco, D Cotton, S Ōunpuu, WA Lawton, ...
New England Journal of Medicine 359 (12), 1225-1237, 2008
8152008
Blood pressure reduction and secondary prevention of stroke and other vascular events: a systematic review
P Rashid, J Leonardi-Bee, P Bath
Stroke 34 (11), 2741-2748, 2003
7682003
High blood pressure in acute stroke and subsequent outcome: a systematic review
M Willmot, J Leonardi-Bee, PMW Bath
Hypertension 43 (1), 18-24, 2004
6762004
Influence of platelet size on outcome after myocardial infarction
JF Martin, PMW Bath, ML Burr
The Lancet 338 (8780), 1409-1411, 1991
6361991
Magnesium for acute stroke (Intravenous Magnesium Efficacy in Stroke trial): randomised controlled trial
Intravenous Magnesium Efficacy in Stroke (IMAGES) Study Investigators
The Lancet 363 (9407), 439-445, 2004
4782004
A randomized trial of anticoagulants: versus aspirin after cerebral ischemia of presumed arterial origin
FWA Verheugt
4541997
The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial
EC Sandset, PMW Bath, G Boysen, D Jatuzis, J Kõrv, S Lüders, ...
The Lancet 377 (9767), 741-750, 2011
4492011
Interventions for dysphagia in acute stroke
PMW Bath, FJ Bath‐Hextall, D Smithard
Cochrane Database of Systematic Reviews, 1999
445*1999
Nitric oxide and prostacyclin. Divergence of inhibitory effects on monocyte chemotaxis and adhesion to endothelium in vitro.
PM Bath, DG Hassall, AM Gladwin, RM Palmer, JF Martin
Arteriosclerosis and thrombosis: a journal of vascular biology 11 (2), 254-260, 1991
4251991
Publication bias in reports of animal stroke studies leads to major overstatement of efficacy
ES Sena, HB Van Der Worp, PMW Bath, DW Howells, MR Macleod
PLoS biology 8 (3), e1000344, 2010
4032010
Association of mean platelet volume with risk of stroke among 3134 individuals with history of cerebrovascular disease
P Bath, C Algert, N Chapman, B Neal
Stroke 35 (3), 622-626, 2004
3712004
IST Collaborative group
J Leonardi-Bee, PM Bath, SJ Phillips, PA Sandercock
Blood pressure and clinical outcomes in the International Stroke Trial …, 2002
3412002
Tinzaparin in acute ischaemic stroke (TAIST): a randomised aspirin-controlled trial
PMW Bath, E Lindenstrom, G Boysen, P De Deyn, P Friis, D Leys, ...
The Lancet 358 (9283), 702-710, 2001
3102001
Good laboratory practice: preventing introduction of bias at the bench
MR Macleod, M Fisher, V O'collins, ES Sena, U Dirnagl, PMW Bath, ...
Stroke 40 (3), e50-e52, 2009
3062009
The system can't perform the operation now. Try again later.
Articles 1–20